Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice
David M. Alvarado, Matthew A. Ciorba, Siyuan Ding(Soochow University), Larissa B. Thackray(Washington University in St. Louis), Sarada C. Prasad(Washington University in St. Louis), Xueyang Cui(Washington University in St. Louis), Michael Diamond(Washington University in St. Louis), Naomi Sonnek(Washington University in St. Louis), Juhee Son(Washington University in St. Louis), María Florencia Gómez Castro(Washington University in St. Louis)
Cited by 7
Related Papers
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
The continued threat of emerging flaviviruses
|Nature Microbiology|2020|1.1k
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
|Science Immunology|2020|1.1k